A literature survey on the biomarkers of cardiovascular disease

IF 0.3 Q3 MEDICINE, GENERAL & INTERNAL

International Journal of Academic Medicine Pub Date : 2021-07-01 DOI:10.4103/IJAM.IJAM_80_20

R. Pavithra, T. Sangeetha, S. Velayuthaprabhu, A. Anand

{"title":"A literature survey on the biomarkers of cardiovascular disease","authors":"R. Pavithra, T. Sangeetha, S. Velayuthaprabhu, A. Anand","doi":"10.4103/IJAM.IJAM_80_20","DOIUrl":null,"url":null,"abstract":"Biomarkers of any condition will help in predicting the disease that can help in improvised treatment and medication. Due to lack of symptoms and precursors, cardiovascular disease (CVD) is one of the leading reasons for death in population all over the world. To reduce the death rate and improve the therapeutic approach, biomarkers related to CVD can be helpful. The study of the levels of biomarkers in the body can help in predicting the chances of CVD. The literature study of biomarkers of CVD is to analyze the biomarkers and their role and levels in causing CVD. Among the various analyzed lipid-related markers like apolipoprotein B, apolipoprotein A1, lipoprotein (a), high-sensitivity cardiac troponin, high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, coronary artery calcification, cystatin C, it has been identified that the cystatin C is the biomarker for not only the chronic kidney disease but also a predictor of major CVD events. The following core competencies are addressed in this article: Medical knowledge, Patient care, Systems-based practice.","PeriodicalId":36495,"journal":{"name":"International Journal of Academic Medicine","volume":"7 1","pages":"141 - 149"},"PeriodicalIF":0.3000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Academic Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/IJAM.IJAM_80_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Biomarkers of any condition will help in predicting the disease that can help in improvised treatment and medication. Due to lack of symptoms and precursors, cardiovascular disease (CVD) is one of the leading reasons for death in population all over the world. To reduce the death rate and improve the therapeutic approach, biomarkers related to CVD can be helpful. The study of the levels of biomarkers in the body can help in predicting the chances of CVD. The literature study of biomarkers of CVD is to analyze the biomarkers and their role and levels in causing CVD. Among the various analyzed lipid-related markers like apolipoprotein B, apolipoprotein A1, lipoprotein (a), high-sensitivity cardiac troponin, high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, coronary artery calcification, cystatin C, it has been identified that the cystatin C is the biomarker for not only the chronic kidney disease but also a predictor of major CVD events. The following core competencies are addressed in this article: Medical knowledge, Patient care, Systems-based practice.

查看原文本刊更多论文

心血管疾病生物标志物的文献综述

任何疾病的生物标记都有助于预测疾病，从而有助于临时治疗和药物治疗。由于缺乏症状和前兆，心血管疾病(CVD)是全球人口死亡的主要原因之一。为了降低死亡率和改善治疗方法，与心血管疾病相关的生物标志物可能会有所帮助。对体内生物标志物水平的研究有助于预测心血管疾病的发生几率。CVD生物标志物的文献研究是分析生物标志物及其在CVD发病中的作用和水平。在各种已分析的脂质相关标志物中，如载脂蛋白B、载脂蛋白A1、脂蛋白(a)、高敏心肌肌钙蛋白、高敏C反应蛋白、脂蛋白相关磷脂酶A2、冠状动脉钙化、胱抑素C，已确定胱抑素C不仅是慢性肾脏疾病的生物标志物，而且是主要心血管疾病事件的预测因子。本文讨论了以下核心能力:医学知识、患者护理、基于系统的实践。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Academic Medicine Social Sciences-Education

CiteScore

1.10

自引率

0.00%

发文量